USRM (US Stem Cell) OCF Yield %: 0.00 (As of Jun. 26, 2026)


USRM US Stem Cell Inc USRM
12 GF Score
Price $0.00
View Full Analysis

What is US Stem Cell OCF Yield %?

US Stem Cell USRM -99.00% 12 OCF Yield % is 0.00 as of Jun. 26, 2026. GuruFocus rates USRM with a GF Score™ of 12/100.

OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

As of today, US Stem Cell's Trailing 12-Month Cash Flow from Operations is $-0.31 Mil, and Market Cap is $0.00 Mil. Therefore, US Stem Cell's OCF Yield % for today is 0.00%.

The historical rank and industry rank for US Stem Cell's OCF Yield % or its related term are showing as below:


During the past 13 years, the highest OCF Yield % of US Stem Cell was 9907300.00%. The lowest was -12948800.00%. And the median was %.

USRM's OCF Yield % is not ranked *
in the Biotechnology industry.
Industry Median: -8.48
* Ranked among companies with meaningful OCF Yield % only.

US Stem Cell's OCF Margin % for the quarter that ended in Dec. 2022 was %.

US Stem Cell OCF Yield % Explanation

Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

US Stem Cell OCF Yield % Related Terms

US Stem Cell OCF Yield % Historical Data

* Premium members only.

The historical data trend for US Stem Cell's OCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

US Stem Cell OCF Yield % Chart

US Stem Cell Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
OCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.95 -82.83 -9.01 -35.02 -10.02

US Stem Cell Quarterly Data
Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22
OCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -28.73 -4.76 -15.88 -6.74 -5.65
USRM
12GF Score
US Stem Cell Inc USRM
OCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

US Stem Cell OCF Yield % Calculation

OCF Yield % is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

US Stem Cell's OCF Yield % for the fiscal year that ended in Dec. 2022 is calculated as

OCF Yield %=Cash Flow from Operations / Market Cap
=-0.305 / 3.0451344
=-10.02%

US Stem Cell's annualized OCF Yield % for the quarter that ended in Dec. 2022 is calculated as

OCF Yield %=Cash Flow from Operations * Annualized Factor / Market Cap
=-0.043 * 4 / 3.0451344
=-5.65%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Yield % →
What does a OCF Yield % of 0.00 mean?
US Stem Cell (USRM) has a OCF Yield % of 0.00 as of Jun. 26, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on US Stem Cell and its competitors.
Is US Stem Cell's OCF Yield % too high?
US Stem Cell's current OCF Yield % is 0.00. Overall, US Stem Cell has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does US Stem Cell's OCF Yield % compare to NOVNQ and RGRX?
US Stem Cell's OCF Yield % of 0.00 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Biotechnology company?
A good OCF Yield % depends on the Biotechnology industry context. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on US Stem Cell and its competitors. US Stem Cell's current OCF Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is US Stem Cell stock overvalued right now?
US Stem Cell (USRM) has a current OCF Yield % of 0.00. The current OCF Yield % is 0.00. US Stem Cell's overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For US Stem Cell (USRM), the current OCF Yield % is 0.00 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

US Stem Cell Business Description

Address 1560 Sawgrass Corporate Parkway, 4th Floor, Sunrise, FL, USA, 33323
US Stem Cell Inc is a biotechnology company engaged in the discovery and development of autologous cell therapies for the treatment of chronic and acute heart damage. Its product includes MyoCell, a clinical therapy designed to populate regions of scar tissue within a patient's heart with autologous muscle cells, or cells from a patient's body, for the purpose of improving cardiac function in chronic heart failure patients. The company's discoveries include multiple cell therapies in various stages of development that repair damaged tissues throughout the body due to injury or disease so that patients may return to a normal lifestyle.
12GF Score

Get the complete analysis for USRM

OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price